Benign and malignant haematological and genetic disorders.
HSCT, HSCT complications (GVHD, infection, etc.).
Chinese Board of Internal Medicine
Education and training
Visiting Fellow, M.D. Anderson Cancer Center (2011)
M.D., Peking University Health Science Center (2005)
Bachelor, Shandong Medical University
Clinical Associate Professor, HSCT Department, Lu Daopei Hospital (2005-present)
The Gold Medal Doctor by China Charity Federation in 2010
1、Haploidentical blood and bone marrow transplantation for advanced chronic myeloid leukaemia.
ZHAO Yanli, WU Tong, ZHANG Yao-chen, CAOXing-yu, YIN Yu-ming, WANG Jing-bo, ZHOU Jia-rui, SUN Rui-juan, LU Yue, ZHANG Jian-ping, JI Shu-quan, LU Dao-pei.(2012).Haploidentical blood and marrow transplantation for advanced chronic myeloid leukemia.Chinese Journal of Organ Transplantation,33( 02 ): 73-76.
Participated in the editing of books.
Participated in editing the second edition of "Leukaemia Therapeutics", edited the chapter of "Chronic Myeloid Leukaemia" and "Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukaemia".
Making speech and wall newspaper exchange
1、Haplotype hematopoietic stem cell transplantation for advanced chronic myeloid leukemia， made speech and wall newspaper exchange In the 2008 Asia Pacific bone marrow transplant Conference (APBMT) and the 2009 European Blood Conference (EHA)
2、Sibling allogeneic hematopoietic stem cell transplantation for 49 patients with chronic myelogenous leukemia，made speech at the fifth Chinese Conference on Oncology.
3、Together infusion Semi identical bone marrow and Non consanguineoustransplantation can reduce acute GVHD after transplantation，made speech and wall newspaper exchange In the 2010 Asia Pacific bone marrow transplant Conference (APBMT) and the2011 American bone marrow transplant annual meeting (ASBMT).
4、Chronic myeloid leukemia is similar to non sibling allograft transplantation in the first chronic phase, made wall newspaper exchange In the 2011 Asia Pacific bone marrow transplant Conference (APBMT)
5、Improved Outcomes of Haploidentical Blood and Marrow Transplantation with GIAC-3 Protocol That Haploidentical Bone Marrow from the Second Donor as the Third Party Cells, made wall newspaper exchange In the 2014 American Society of Hematology Annual Meeting（ASH ）.
6、Haploidentical Hematopoietic Stem Cell Transplantation after myeloablative conditioning for acute myeloid leukemia : A Single-Center Study of 230 Cases ,made oral report in the 2014 Asia Pacific bone marrow transplant Conference (APBMT) .
7、Improved Outcomes of Haploidentical Blood and Marrow Transplantation in Hematologic Malignancies: A Single Center Study of 514 Cases. made wall newspaper exchange In the 2015 American Society of Hematology Annual Meeting（ASH ）.